CN105596311A — 一种利奥西呱口服固体制剂及其制备方法
Assigned to ZHENGZHOU DAMING PHARMACEUTICAL TECHNOLOGY Co Ltd · Expires 2016-05-25 · 10y expired
What this patent protects
本发明提供了一种包含利奥西呱的固体药物制剂,按照重量份数计算,所述1mg规格的利奥西呱口服固体制剂由利奥西呱1mg、填充剂60~80mg、粘合剂2~8mg、崩解剂2~8mg、润滑剂0.5~1.5mg组成。本发明提供的固体药物制剂采用固体分散技术,通过将主药与填充剂混合研磨,提高主药的溶解性,提升溶出效果,确保制剂溶出速率快,含量均匀度高,生物利用度高。本发明制备工艺生产工艺简单,成本低,适于工业化生产。
USPTO Abstract
本发明提供了一种包含利奥西呱的固体药物制剂,按照重量份数计算,所述1mg规格的利奥西呱口服固体制剂由利奥西呱1mg、填充剂60~80mg、粘合剂2~8mg、崩解剂2~8mg、润滑剂0.5~1.5mg组成。本发明提供的固体药物制剂采用固体分散技术,通过将主药与填充剂混合研磨,提高主药的溶解性,提升溶出效果,确保制剂溶出速率快,含量均匀度高,生物利用度高。本发明制备工艺生产工艺简单,成本低,适于工业化生产。
Drugs covered by this patent
- Adempas (RIOCIGUAT) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.